Decoding Pathogenesis of Slow-Channel Congenital Myasthenic Syndromes using Recombinant Expression and Mice Models

Gelijkaardige items

• Fluoxetine is neuroprotective in slow-channel congenital myasthenic syndrome
  door: Zhu, Haipeng, et al.
  Gepubliceerd in: (2014)
• Potential role of caveolin-1-positive domains in the regulation of the acetylcholine receptor’s activatable pool: Implications in the pathogenesis of a novel congenital myasthenic syndrome
  door: Báez-Pagán, Carlos A., et al.
  Gepubliceerd in: (2008)
• Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment
  door: Engel, Andrew G., et al.
  Gepubliceerd in: (2015)
• Lateral Diffusion, Function, and Expression of the Slow Channel Congenital Myasthenia Syndrome αC418W Nicotinic Receptor Mutation with Changes in Lipid Raft Components
  door: Oyola-Cintrón, Jessica, et al.
  Gepubliceerd in: (2015)
• Fourier transform coupled to tryptophan-scanning mutagenesis: Lessons from its application to the prediction of secondary structure in the acetylcholine receptor lipid-exposed transmembrane domains
  door: Otero-Cruz, José David, et al.
  Gepubliceerd in: (2008)